The Consortium of Canadian Centres for Clinical Cognitive Research (C5R)
is a non profit collaborative research network that links pharmaceutical companies and researchers collaborating on clinical trials in the desire to research and develop treatments for patients with mild cognitive impairment and dementia.
C5R has 33 accredited sites in Canada, with 55 full members, 53 associate members and 2 corporate members.
Some of the capabilities of our research sites include MRI (1.5T, 3.0T, 7.0T, FMRI, MR Spectroscopy), PET Lumbar Puncture, Cyclotron, and IV/SQ therapies.
We are equipped to undertake any new clinical trial in dementia or Mild Cognitive Impairment in phase I, II, III or IV.
C5R is a single point of contact for the coordination of the Clinical Research Centres and Memory Clinics studying and treating dementia in Canada. All clinical trial needs are managed centrally through our Calgary based headquarters.
- expert scientific review of clinical trial protocol
- centrally negotiated budget for all C5R research sites
C5R is currently conducting a number of multi-centre clinical trials. Click here for more information regarding our current research…
Interested in conducting your clinical trial
with C5R? Contact us!